Platinum Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Platinum Investment Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-93,940	Closed	-$7.6M	–	144
2022 Q1	$7.6M	Buy	93,940 +22,543	+32%	+$1.91M	0.23%	51
2021 Q4	$7.33M	Sell	71,397 -9,444	-12%	-$907K	0.2%	54
2021 Q3	$7.07M	Sell	80,841 -26,913	-25%	-$2.44M	0.2%	53
2021 Q2	$9.64M	Buy	107,754 +46,541	+76%	+$3.93M	0.22%	46
2021 Q1	$4.64M	Buy	61,213 +13,374	+28%	+$1.01M	0.1%	55
2020 Q4	$3.26M	Buy	+47,839	New	+$2.98M	0.07%	67

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Platinum Investment Management's SYNH Position: Q2 2022 in Review

Platinum Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2022, closing a stake of 93,940 shares — an estimated $7.6M sold.

Platinum Investment Management first reported a position in SYNH in Q4 2020 and held it in 6 quarters. The position peaked at $9.64M in Q2 2021. 362 funds tracked by Wall St. Rank hold SYNH as of Q2 2022.

Platinum Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Platinum Investment Management sold 93,940 Syneos Health, Inc. Class A Common Stock shares in Q2 2022, an estimated $7.6M.
Platinum Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 6 quarters.
Platinum Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $9.64M in Q2 2021.
362 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2022.

Based on Platinum Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.